Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer

Progression-Free Survival: Meaningful or Simply Measurable?

(2012) Christopher M. Booth et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Poor correlation between progression-free and overall survival in modern clinical trials: Are composite endpoints the answer?

(2011) Eitan Amir et al.   EUROPEAN JOURNAL OF CANCER

Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review

(2011) Benoit You et al.   JOURNAL OF CLINICAL ONCOLOGY

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

(2011) Javier Cortes et al.   LANCET

Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary Outcomes

(2010) Isabelle Boutron   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

When Are "Positive" Clinical Trials in Oncology Truly Positive?

(2010) A. Ocana et al.   JNCI-Journal of the National Cancer Institute

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

(2010) Luca Gianni et al.   LANCET

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer

(2010) Miguel Martín et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bias Due to Changes in Specified Outcomes during the Systematic Review Process

(2010) Jamie J. Kirkham et al.   PLoS One

Adverse Events in Randomized Trials

(2009) John P. A. Ioannidis   ARCHIVES OF INTERNAL MEDICINE

Reporting of Safety Results in Published Reports of Randomized Controlled Trials

(2009)   ARCHIVES OF INTERNAL MEDICINE

Endpoints for Assessing Drug Activity in Clinical Trials

(2008) R. Pazdur   ONCOLOGIST

Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias

(2008) Kerry Dwan et al.   PLoS One

Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation

(2008) Kristin Rising et al.   PLOS MEDICINE